Organization for Economic Co-Operation and Development (OECD) Addresses Aging During 50th Anniversary Conference

Global Coalition on Aging Presents Keynote Address on Aging, Health and Innovation

PARIS, FRANCE (June 22, 2011) – Today the Global Coalition on Aging in partnership with the International Longevity Centre-UK (ILC-UK), took a leading role in addressing the critical issue of aging populations in the 34 countries of the Organization for Economic Co-operation and Development (OECD). During today’s OECD Conference on Health Reform, Michael Hodin, Executive Director of the Global Coalition discussed the impact of aging on OECD nations and cited examples of policy reforms and innovative business solutions to promote healthy and active aging in OECD countries.

A paper titled, “Ageing, Health and Innovation: Policy Reforms to Facilitate Healthy and Active Ageing in OECD Countries,” authored by Rebecca Taylor, Senior Researcher for the ILC-UK, reports, “A larger older population and a comparatively smaller working age population can put a strain on publicly funded health and social services including healthcare, social care, and pensions, which demands a policy response from OECD governments.” The ILC-UK is led by Baroness Sally Greengross, one of the leading and innovative voices on population aging in the UK and across all OECD countries.

The increase in life expectancy combined with the decline in fertility rates is leading to a dramatic shift in the size of the working population requiring OECD nations to find and adapt innovative solutions beyond reducing benefits and increasing taxes and social security contributions. For instance, in the EU it is predicted that the working population could decline from 277 million in 2005 to 183 million in 2040. This societal shift is demonstrated in the OECD dependency ratio (the ratio of working-age people to people of non-working age), which will fall on average from 7.21 in 1950 to 3.34 in 2020 to 2.08 in 2050.

“OECD nations should look at the rise in aging populations as a means for opportunity and wealth creation, rather than one of disability and dependence. By viewing aging with a life-course approach in which all members of society contribute throughout their lives and older people are a source of knowledge and experience, these countries will position themselves to make the most of the gift that 20th-century longevity has bestowed on us and be the winners of the 21st-century competitiveness race,” said Hodin.

The paper also highlights some of the most exciting innovative policies and market solutions that are being deployed across OECD nations to keep people healthier longer and out of hospitals and in their communities. New policies that consider aging holistically will mitigate the strain that demographic change might have on OECD nations and ensure that older people are active and productive – whether as workers, consumers, volunteers, or caregivers.

OECD nations include Australia, Austria, Belgium, Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, and the United States.

Click here for Business Industry Advisory Committee press release.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.